CDX2 is an amplified lineage-survival oncogene in colorectal cancer. - Wikidata - awgldk - TriplyDB

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

http://www.wikidata.org/entity/Q36414685

about

Patterns of Chromosomal Aberrations in Solid Tumors Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth Modified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier.A novel CDX2 isoform regulates alternative splicing.SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis.Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer.CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses.Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.Genomic insights into WNT/β-catenin signaling.Glucose-dependent insulinotropic polypeptide-mediated signaling pathways enhance apical PepT1 expression in intestinal epithelial cells.Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.Precise integration of inducible transcriptional elements (PrIITE) enables absolute control of gene expression.Involvement of the Integrin α1β1 in the Progression of Colorectal Cancer.Decreased FOXJ1 expression and its ciliogenesis programme in aggressive ependymoma and choroid plexus tumours.Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.Cdx1 and Cdx2 function as tumor suppressors.A tumor profile in Patau syndrome (trisomy 13).Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway

P2860

Q26786127-E4431F0D-8F26-4CB6-B2AF-0ED669416042 Q30854226-C046E8C5-F211-4538-B3AF-CE8BA9184439 Q34418393-1837AFF6-CDB5-4FFF-ABF4-521443F62E75 Q35187370-0B654C97-E8CC-4CD3-9996-C45D8BB205D5 Q35220948-9FAF8A13-D0DD-4371-A65F-04D2EF98757D Q36202378-D9A5DFD4-0654-422F-980D-72F1E2B19C19 Q36509342-A5585253-0B99-412A-A7BD-D13C3ED599E7 Q36515055-D1DD6491-A692-44D2-B1EA-E536A626F922 Q36705808-4FC2B3B7-ACEA-4951-8F14-7CAD9A7241C2 Q37529458-5F8252EC-44BF-4FF5-A9F1-DBAF163382E7 Q38173593-754B87CF-B567-439A-9F5D-DD75BDE9B7DB Q38942120-8B6B73FC-A515-4629-B4D0-365073BD614D Q39029136-B3F4DBC0-9502-4175-A548-83638139F50D Q41510767-E03EAACB-6D2C-4AC1-B882-A625C7D7A07B Q41552584-347BC722-CF7D-478C-8A5F-7265576AA640 Q41896783-BA6D20CE-6F49-4E95-B815-2E41CB264DFD Q42513461-FC40543F-996B-4A39-AE19-7D70D6528BED Q43041245-6BF34550-7A7A-45B3-85D3-317EBD8D51F2 Q52093733-D5A0A65D-A088-49DB-B60A-EA402CC36020 Q52603962-BDDC356E-15B5-4ADF-B7B1-F04867803E1B Q55251613-82413ED8-CCEE-4383-AA14-E9799F729A67 Q58695221-50D1901D-4A13-4647-8948-6DE8E3825E4D

P2860

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

http://www.wikidata.org/entity/Q36414685

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

@ast

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

@en

type

label

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

@ast

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

@en

prefLabel

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

@ast

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

@en

P1433

Q36414685-885B13A2-379C-4A86-8BF1-EDE3B76366C2

P1476

Q36414685-63557776-82D0-40A0-941F-F1D4FA03D7A2

P2093

Q36414685-723ABE27-098F-4C28-A675-D35E5D4E0756

Q36414685-86BA180C-DD01-45ED-87CC-CD663FD57968

Q36414685-89E24C15-F6B4-40EA-804E-48192E159AEE

Q36414685-98619C61-C0BE-4D03-8722-7B272D15F987

Q36414685-A306FEFD-8F2C-49DA-9DC9-3D720295C6A6

Q36414685-D2B8249B-771A-4787-BB4C-12CCE579D2A7

Q36414685-E5F0CE4F-7758-47C3-9FDC-7776645E3A7F

Q36414685-FC02DE85-2D43-4990-8CC8-440CEBDCB825

P2860

Q36414685-02BB8944-ED1C-4373-8E6F-31FAE762CDF9

Q36414685-08940C8F-7EE2-4FA9-BB86-B69AF9E850EB

Q36414685-09099DDA-F693-471C-ABD0-954DC63D8956

Q36414685-09A94DFA-38AD-4A53-9E7A-BE5348429D61

Q36414685-166A07C8-0493-403D-A5B8-3A73F95C270B

Q36414685-196DCD06-24D2-4283-A252-1A9053A49013

Q36414685-1B83F6BA-9CBE-4767-A9B7-92B9655FDE0F

Q36414685-24B67E60-3E47-4FD8-9CD9-8B9044396C05

Q36414685-2AB2ABBB-1F12-4606-B79E-D3DB25AC78DA

Q36414685-2C2DED24-7C2A-4B93-A6A0-DB6A21B22210

P304

Q36414685-1CB56AC2-3110-4F68-A647-972F66EB2DD5

P31

Q36414685-C5E09544-1B96-4797-8398-23B07934DA35

P356

Q36414685-8A6FAA53-FFFF-4FB2-A197-6DB29786B954

P407

Q36414685-8C18859B-9BB5-4624-86A6-9086D7A522AB

P433

Q36414685-CCD28B0B-7309-46FD-AADD-E3A15A2F17A6

P478

Q36414685-9CA21594-2D95-4095-B31E-9F6253668E5A

P50

Q36414685-59C1F348-783E-4798-9EB1-CBD4760B97E0

Q36414685-AE93CB54-EFBA-4EE2-B72B-F39017BA0572

P577

Q36414685-4CCC8A91-4519-4620-826B-4188C2C554B6

P5875

Q36414685-2415242A-A2F6-4C36-96D4-9197CF939F6B

P698

Q36414685-DDC6288E-1FCB-4663-BDB1-89B7E1195F75

P921

Q36414685-5639BDE2-0985-428F-A2A4-F6CD0FFD8F40

P932

Q36414685-0667AE0C-A9F8-4E1A-91B1-A98B64843A1C

P356

PNAS.1206004109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

@en

P2093

Albert Y Lin

http://www.w3.org/2001/XMLSchema#string

Andrew D Forster

http://www.w3.org/2001/XMLSchema#string

Craig P Giacomini

http://www.w3.org/2001/XMLSchema#string

Justin Cuff

http://www.w3.org/2001/XMLSchema#string

Keyan Salari

http://www.w3.org/2001/XMLSchema#string

Mary E Spulak

http://www.w3.org/2001/XMLSchema#string

Melissa E Ko

http://www.w3.org/2001/XMLSchema#string

Stephanie Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Frizzled-8 as a putative therapeutic target in human lung cancer

Homeosis and intestinal tumours in Cdx2 mutant mice

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Cdx2 is essential for axial elongation in mouse development

Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia

Comprehensive molecular characterization of human colon and rectal cancer

Characterizing the cancer genome in lung adenocarcinoma.

Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer

P304

E3196-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1206004109

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Matt van de Rijn

Jonathan R. Pollack

P577

2012-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232741908

http://www.w3.org/2001/XMLSchema#string

P698

23112155

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3503165

http://www.w3.org/2001/XMLSchema#string